Biotech & AI Investment Fund
Transforming Medicine and AI for a Healthy, Sustainable Tomorrow
Axmra Capital is a deep-science investment platform advancing breakthrough science and technology that redefines human health and progress. Axmra Capital backs visionary teams translating deep scientific insight and artificial intelligence into transformative global solutions.
Portfolio
Portfolio Companies
Riboscience 1
Delivering next-generation immuno-oncology therapeutics. Best-in-class, oral, and non-toxic drug candidate has demonstrated excellent safety and efficacy in Phase 1/1b clinical trials and is now advancing through multiple Phase 2 studies.
4J Therapeutics 1
4J Therapeutics is developing a novel, broad-spectrum therapeutic using its programmable anti-viral platform. It is currently advancing a pan-influenza therapeutic toward market.
1 Portfolio investments are through a related fund.
Get In Touch
Contact Us
Important Regulatory Information
Qualified Investors Only: This website and the information contained herein is intended solely for accredited investors, qualified purchasers, and professional investors as defined under applicable securities laws. Investment in the Fund involves substantial risk and is suitable only for sophisticated investors who can bear the loss of their entire investment.
Not an Offer: Nothing on this website constitutes an offer to sell, or a solicitation of an offer to buy, any securities in any jurisdiction where such offer or solicitation would be unlawful. Any offer or solicitation will be made only by means of a confidential private placement memorandum and subject to the terms and conditions contained therein.
Risk Factors: Investment in biotechnology and early-stage companies involves significant risks including loss of capital, illiquidity, regulatory uncertainty, and extended investment horizons. Past performance is not indicative of future results.